Cargando…

Erratum to: CAR T Cell Therapy for Hematological Malignancies

Detalles Bibliográficos
Autores principales:	Yang, Xin, Wang, Gao-xiang, Zhou, Jian-feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Huazhong University of Science and Technology 2021
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184548/ https://www.ncbi.nlm.nih.gov/pubmed/33582925 http://dx.doi.org/10.1007/s11596-020-2280-3

Ejemplares similares

CAR T-Cell Therapy in Hematological Malignancies
por: Haslauer, Theresa, et al.
Publicado: (2021)

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
por: Gamonet, Clémentine, et al.
Publicado: (2016)

The journey of CAR-T therapy in hematological malignancies
por: Lu, Junru, et al.
Publicado: (2022)

Current Progress in CAR-T Cell Therapy for Hematological Malignancies
por: Han, Donglei, et al.
Publicado: (2021)

CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
por: Zhang, Xiaomin, et al.
Publicado: (2022)

CAR-T cell therapy for hematological malignancies: History, status and promise
por: Wang, Chao, et al.
Publicado: (2023)

Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
por: Wang, Hao, et al.
Publicado: (2019)

Challenges and optimal strategies of CAR T therapy for hematological malignancies
por: Zhang, Yajing, et al.
Publicado: (2023)

Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
por: Cao, Xinping, et al.
Publicado: (2023)

Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies
por: Lin, Wen-Ying, et al.
Publicado: (2020)

The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies
por: Guo, Zilong, et al.
Publicado: (2021)

The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
por: Zhao, Zijun, et al.
Publicado: (2018)

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies
por: Stadtmauer, Edward, et al.
Publicado: (2017)

CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
por: Huang, Jiawen, et al.
Publicado: (2022)

Erratum to “Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours”
por: Trojan, Jerzy, et al.
Publicado: (2012)

Erratum to: A panel of four genes accurately differentiates benign from malignant thyroid nodules
por: Wang, Qing-Xuan, et al.
Publicado: (2017)

Erratum to: Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells
por: Barar, Jaleh, et al.
Publicado: (2015)

T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
por: Tang, Lu, et al.
Publicado: (2021)

Erratum: Congenital Malignant Rhabdoid Tumor of Neck
Publicado: (2023)

Erratum to: Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
por: Liu, Dongfang, et al.
Publicado: (2017)

Abstract 2 Development of CAR-NK Cell Therapy for Hematologic Malignancies
por: Stoltzman, Carrie, et al.
Publicado: (2022)

Clinical Strategies for Enhancing the Efficacy of CAR T-Cell Therapy for Hematological Malignancies
por: Liu, Qianzhen, et al.
Publicado: (2022)

T cell senescence and CAR-T cell exhaustion in hematological malignancies
por: Kasakovski, Dimitri, et al.
Publicado: (2018)

Erratum to anti-GD2 CAR T cells could prove transformative for H3-K27M(+) diffuse midline gliomas
por: Furukawa, Koichi, et al.
Publicado: (2019)

Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies
por: Marei, Hany E., et al.
Publicado: (2023)

A “Bone Marrow Score” for Predicting Hematological Disease in Immunocompetent Patients With Fevers of Unknown Origin: Erratum
Publicado: (2016)

Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies
por: Abbasi, Samane, et al.
Publicado: (2022)

Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies
por: Jacoby, Elad
Publicado: (2019)

Erratum: Evaluation of thrombocytopenia in the hematology clinic: a case series from a large tertiary care center
Publicado: (2019)

Erratum: Evaluation of thrombocytopenia in the hematology clinic: a case series from a large tertiary care center
Publicado: (2018)

The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy: Erratum
por: Guo, Qiang, et al.
Publicado: (2020)

Erratum: Mirror neuron therapy for hemispatial neglect patients
por: Wang, Wei, et al.
Publicado: (2015)

From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
por: Lu, Hui, et al.
Publicado: (2021)

An ‘off-the-shelf’ fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
por: Cooper, Matthew L., et al.
Publicado: (2018)

Erratum to “Are the review criteria for automated complete blood counts of the International Society of Laboratory Hematology suitable for all hematology laboratories?” [Rev. Bras. Hematol. Hemoter. 2014;36(3):219–225]
por: Comar, Samuel Ricardo, et al.
Publicado: (2014)

Erratum to: Sexual behavior of migrant workers in Shanghai, China
por: Dai, Wei, et al.
Publicado: (2016)

Resistance Mechanisms to CAR T-Cell Therapy and Overcoming Strategy in B-Cell Hematologic Malignancies
por: Song, Moo-Kon, et al.
Publicado: (2019)

Erratum: predictors of malignancy in pancreatic head mass: a prospective study
Publicado: (2016)

Erratum: Outcomes of the Multimodal Treatment of Malignant Pleural Mesiothelioma: The Role of Surgery
por: Na, Bub-Se, et al.
Publicado: (2018)

Whole Body CT Imaging in Deceased Donor Screening for Malignancies: Erratum
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8hv8emikp72ps3t63idj4mpuim